Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
6h
WKRG on MSNGov. Reeves tours tornado damage in MississippiGovernor Tate Reeves (R-Miss.) toured the tornado damage in the Pine Belt from Saturday’s severe storms. On Monday, the ...
Washington Township supervisors discussed the Emergency Management Report from Joe Mead this month. The Lehigh Emergency Management Agency’s quarterly meeting was held on Feb. 6. The meeting ...
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, March 17, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: ...
When comparing the FDA and EMA, we found that many of the calculations that determine this relative speed have used time of approval and time of market authorization, interchangeably. This ...
The Ohio Controlling Board approved the funds for the 2025 North ... $100K to the Ohio Emergency Management Agency (Ohio EMA). The funds will be disbursed on a rolling reimbursement basis to ...
A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi to children as young as six if they have specific gene mutations. The regulator has given a green light ...
FEMA approved Michigan’s request for a federal disaster declaration after a series of floods devastated the Detroit area in August 2023. The disaster declaration allowed residents to apply for ...
For drugs not yet approved in any EU Member State, allowing manufacturers to apply for authorisation in multiple EU countries at the same time. With offices across the EU, Proregulations can ...
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate
Exogenus Therapeutics and Lonza agreed to collaborate on the development of Exo-101, Exogenus’ exosome-based lead candidate. The company specializes in the development of therapeutics based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results